Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59694-0 Hydroxytriazolam MCnt Meconium Pt Qn Confirm   ACTIVE Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59694-0   Confirm     Both       0 OH-Triazolam Mec Cfm-mCnt       N   Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; Mass content; Mec; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite 2.7 2.32               ng/g       0
59695-7 Hydroxytriazolam MCnt Tiss Pt Qn     ACTIVE Hydroxytriazolam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59695-7         Both       0 OH-Triazolam Tiss-mCnt       N   Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydroxy triazolam; Illicit; Mass Content; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Triazolam metabolite 2.7 2.32               ng/g       0
59696-5 Hydroxytriazolam MCnt Tiss Pt Qn Confirm   ACTIVE Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59696-5   Confirm     Both       0 OH-Triazolam Tiss Cfm-mCnt       N   Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; Mass content; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Triazolam metabolite 2.7 2.32               ng/g       0
59697-3 Iodide MCnc Ser/Plas Pt Qn     ACTIVE Iodide [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ug/mL 1 mcg/mL           DRUG/TOX   59697-3         Both       0 Iodide SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.34               ug/mL       0
59699-9 LORazepam MCnc Bld Pt Qn     ACTIVE LORazepam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59699-9         Both       0 LORazepam Bld-mCnc       N   Addiction; Ativan; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
597-5 Bacteria Prid Asp Pt Nom Aerobic culture   ACTIVE Bacteria identified in Aspirate by Aerobe culture   NAM DefinitionDescription                   MICRO   597-5   Aerobic culture     Both       0 Bacteria Aspirate Aerobe Cult           Aerobe; Aerobe Cult; Aerobed; Aspirate; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random 2.78 1                     Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; 0
5970-9 Plasminogen ACnc PPP Pt Qn Chromo   ACTIVE Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic method   MIN DefinitionDescription     CTA U/mL             COAG   5970-9   Chromo     Both       0 PLG PPP Chro-aCnc       Y   Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Plas; Platelet poor plasma; PLG; PLGN; Point in time; Profibrinolysin; QNT; Quan; Quant; Quantitative; Random 2.73 1.0d               {CTA'U}/mL       0
59700-5 LORazepam MCnc Bld Pt Qn Confirm   ACTIVE LORazepam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59700-5   Confirm     Both       0 LORazepam Bld Cfm-mCnc       N   Addiction; Ativan; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.73 2.32               ng/mL       0
59701-3 LORazepam MCnc Body fld Pt Qn     ACTIVE LORazepam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59701-3         Both       0 LORazepam Fld-mCnc       N   Addiction; Ativan; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59702-1 LORazepam MCnc Body fld Pt Qn Confirm   ACTIVE LORazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59702-1   Confirm     Both       0 LORazepam Fld Cfm-mCnc       N   Addiction; Ativan; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random 2.7 2.32               ng/mL       0
59703-9 LORazepam MCnc Ser/Plas Pt Qn Confirm   ACTIVE LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59703-9   Confirm     Both       0 LORazepam SerPl Cfm-mCnc       N   Addiction; Ativan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.32               ng/mL       0
59704-7 LORazepam MCnt Tiss Pt Qn     ACTIVE LORazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59704-7         Both       0 LORazepam Tiss-mCnt       N   Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59705-4 Methadone PrThr Ser/Plas Pt Ord Screen   ACTIVE Methadone [Presence] in Serum or Plasma by Screen method   MIN DefinitionDescription       25 ng/mL           DRUG/TOX   59705-4   Screen     Both       0 Methadone SerPl Ql Scn       N   Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.32                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
59706-2 MethylePHEDrine MCnc Ser/Plas Pt Qn     ACTIVE MethylePHEDrine [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59706-2         Both       0 Me-ePHEDrine SerPl-mCnc       N   Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ivilco; Level; Mass concentration; Me-ePHEDrine; Pholcomed; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tossamine plus 2.7 2.32               ng/mL       0
59707-0 Midazolam MCnc Bld Pt Qn     ACTIVE Midazolam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59707-0         Both       0 Midazolam Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed; WB; Whole blood 2.7 2.32               ng/mL       0
59708-8 Midazolam MCnc Bld Pt Qn Confirm   ACTIVE Midazolam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59708-8   Confirm     Both       0 Midazolam Bld Cfm-mCnc       N   Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed; WB; Whole blood 2.73 2.32               ng/mL       0
59709-6 Midazolam MCnc Body fld Pt Qn     ACTIVE Midazolam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59709-6         Both       0 Midazolam Fld-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed 2.7 2.32               ng/mL       0
5971-7 Plasminogen activator tissue type Ag MCnc PPP Pt Qn IA   ACTIVE Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay   MIN DefinitionDescription     ug/L;ng/mL             COAG   5971-7   IA     Both       0 tPA Ag PPP IA-mCnc       Y   Antigen; Antigens; Blood plasminogen activator; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Level; Mass concentration; MEIA; Plas; Platelet poor plasma; PLG; PLGN; Point in time; Profibrinolysin; QNT; Quan; Quant; Quantitative; Random; SUDS; Tissue plasminogen activator; TPA; t-PA; Vascular plasminogen activator 2.73 1.0d               ug/L     Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). 0
59710-4 Midazolam MCnc Body fld Pt Qn Confirm   ACTIVE Midazolam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59710-4   Confirm     Both       0 Midazolam Fld Cfm-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed 2.7 2.32               ng/mL       0
59711-2 Midazolam MCnc Ser/Plas Pt Qn Confirm   ACTIVE Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59711-2   Confirm     Both       0 Midazolam SerPl Cfm-mCnc       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Versed 2.73 2.32               ng/mL       0
59712-0 Midazolam MCnt Tiss Pt Qn     ACTIVE Midazolam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59712-0         Both       0 Midazolam Tiss-mCnt       N   DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Versed 2.73 2.32               ng/g       0
59713-8 Midazolam MCnt Tiss Pt Qn Confirm   ACTIVE Midazolam [Mass/mass] in Tissue by Confirmatory method   MIN DefinitionDescription     ng/g 5 ng/g           DRUG/TOX   59713-8   Confirm     Both       0 Midazolam Tiss Cfm-mCnt       N   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Versed 2.7 2.32               ng/g       0
59714-6 Nitrous oxide MCnc Bld Pt Qn     ACTIVE Nitrous oxide [Mass/volume] in Blood   MIN DefinitionDescription     ug/mL 1.8 mcg/mL           DRUG/TOX   59714-6         Both       0 N2O Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Laughing gas; Level; Mass concentration; N2O; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ug/mL       0
59715-3 Nitrous oxide MCnc Ser/Plas Pt Qn     ACTIVE Nitrous oxide [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ug/mL 1.8 mcg/mL           DRUG/TOX   59715-3         Both       0 N2O SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Laughing gas; Level; Mass concentration; N2O; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.7 2.32               ug/mL       0
59716-1 Nordiazepam MCnc Bld Pt Qn     ACTIVE Nordiazepam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59716-1         Both       0 Nordiazepam Bld-mCnc       N   Blood; Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan; WB; Whole blood 2.7 2.32               ng/mL       0
104,672 results found